ASAD ISLAM: Open Payments
NPI 1841248846 · LEWISVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,454 in 209 payments from 21 companies in 2025. Trend: 2023 $3,422 · 2024 $3,206 · 2025 $3,454
Food & beverage: $3,099Travel & lodging: $244Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 30 | $551 |
| Neurocrine BioSciences, Inc. | 26 | $495 |
| E.R. Squibb & Sons, L.L.C. | 18 | $417 |
| Lundbeck LLC | 20 | $332 |
| Otsuka America Pharmaceutical, Inc. | 22 | $223 |
| Janssen Pharmaceuticals, Inc | 15 | $205 |
| ABBVIE INC. | 20 | $176 |
| Supernus Pharmaceuticals, Inc. | 12 | $167 |
| Collegium Pharmaceutical, Inc. | 11 | $146 |
| Indivior Inc. | 7 | $139 |
Products named: INGREZZA, REXULTI, UZEDY, VRAYLAR, COBENFY, Qelbree, INVEGA SUSTENNA, Jornay PM.
Industry payments across TX — which companies pay providers there.
